GLENVIEW CAPITAL MANAGEMENT, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001138995

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHigh Turnover how tags are computed

Q3 2025 · 54 positions · Total reported value $4.49B · Top-10 concentration 65.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 87.1% · 103 new · 16 cut · 9 exited

Active Share (vs S&P 500): 86.9% · vs QQQ: 85.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +1.7% · vs SPY -0.4% · Prev Value $5.23B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +1.8% · vs SPY -0.4% · Latest Value $5.56B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC disclosed 54 equity positions with a combined reported value of $4.49B. The filing implies a focused portfolio: its ten largest positions account for 65.1% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.

The largest disclosed positions as of Q3 2025 were CVS ($617.96M), THC ($471.80M), GPN ($427.19M). By sector, the heaviest allocations are Health Care 32.2%, Consumer Discretionary 25.0%. Versus the prior quarter, allocation shifted toward Other (+8.4pp), Industrials (+1.1pp) and away from Health Care (-2.0pp), Consumer Staples (-2.1pp).

Versus the prior quarter, GLENVIEW CAPITAL MANAGEMENT, LLC opened 103 new positions, trimmed 16 and fully exited 9, a turnover rate of 87.1% of positions. The portfolio's overlap with the prior quarter was 59% of names.

The largest new positions opened in Q3 2025 were SPY ($377.52M), Z ($68.55M), ICLR ($65.00M).

Of the 9 positions fully exited versus the prior quarter, the largest were CAR ($45.64M), WDC ($38.43M), JBTM ($29.03M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • SPY STATE STR SPDR S&P 500 ETF T · $377.52M
  • Z ZILLOW GROUP INC · $68.55M
  • ICLR ICON PUB LTD CO · $65.00M
  • ONTO ONTO INNOVATION INC · $34.97M
  • LION LIONSGATE STUDIOS CORP · $34.50M
  • PINS PINTEREST INC · $25.98M
  • LAD LITHIA MTRS INC · $23.42M
  • XYZ BLOCK INC · $23.29M

Fully Exited (vs previous quarter)

  • CAR AVIS BUDGET GROUP INC · prev qtr: $45.64M
  • WDC WESTERN DIGITAL CORP · prev qtr: $38.43M
  • JBTM JBT MAREL CORPORATION · prev qtr: $29.03M
  • W WAYFAIR INC · prev qtr: $27.00M
  • COO COOPER COS INC · prev qtr: $19.97M
  • ON ON SEMICONDUCTOR CORP · prev qtr: $9.13M
  • SNDK SANDISK CORP · prev qtr: $1.18M

Insider Transactions (Form 4)

Latest GLENVIEW CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Glenview Capital Management is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 138 US equity positions with a combined value of $5.56B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-73695 (status: Approved), registered 2012-03-30
  • Regulatory AUM (Form ADV): $6.37B as of 2026-09-15
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds, of which 6 hedge funds

Portfolio Structure

  • 138 positions · $5.56B reported value (Q3 2026)
  • Top 10 holdings = 58.3% of reported value
  • Largest position: GPN (GLOBAL PMTS INC) at 10.4%
  • Average position size: $40.30M

Sector Tilt

  • Health Care 27.8%
  • Consumer Discretionary 24.5%
  • Industrials 21.7%
  • (classified holdings cover 92% of value)

Quarterly Activity

  • Q3 2026: 103 new, 16 added, 16 reduced, 9 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 32.2%
Industrials 10.4%
Technology 10.2%
Other 8.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 8.20M $617.96M 13.76%
13.76%
Hold
2 2.32M $471.80M 10.50%
10.50%
Reduce
3 5.14M $427.19M 9.51%
9.51%
Add
4 566.70K $377.52M 8.40%
8.40%
New
5 16.69M $337.19M 7.51%
7.51%
Add
6 18.51M $201.89M 4.49%
4.49%
Add
7 652.14K $143.19M 3.19%
3.19%
Add
8 282.94K $137.23M 3.06%
3.06%
Add
9 8.34M $113.67M 2.53%
2.53%
Add
10 482.17K $98.57M 2.19%
2.19%
Add
11 1.33M $89.42M 1.99%
1.99%
Add
12 8.25M $81.65M 1.82%
1.82%
Hold
13 1.07M $81.63M 1.82%
1.82%
Reduce
14 351.60K $78.13M 1.74%
1.74%
Add
15 359.79K $76.91M 1.71%
1.71%
Reduce
16 889.67K $68.55M 1.53%
1.53%
New
17 20.38M $66.43M 1.48%
1.48%
Reduce
18 371.42K $65.00M 1.45%
1.45%
New
19 676.98K $56.91M 1.27%
1.27%
Add
20 582.01K $56.16M 1.25%
1.25%
Add
21 2.21M $55.55M 1.24%
1.24%
Reduce
22 2.55M $55.11M 1.23%
1.23%
Add
23 187.76K $54.12M 1.21%
1.21%
Reduce
24 264.42K $52.42M 1.17%
1.17%
Add
25 471.80K $46.22M 1.03%
1.03%
Add
26 56.47K $43.62M 0.97%
0.97%
Add
27 1.38M $40.23M 0.90%
0.90%
Add
28 270.61K $34.97M 0.78%
0.78%
New
29 5.00M $34.50M 0.77%
0.77%
New
30 859.82K $33.97M 0.76%
0.76%
Reduce
31 174.73K $33.19M 0.74%
0.74%
Add
32 4.59M $33.17M 0.74%
0.74%
Hold
33 807.70K $25.98M 0.58%
0.58%
New
34 74.11K $23.42M 0.52%
0.52%
New
35 1.55M $23.42M 0.52%
0.52%
Hold
36 322.32K $23.29M 0.52%
0.52%
New
37 167.64K $21.29M 0.47%
0.47%
New
38 171.92K $21.28M 0.47%
0.47%
Reduce
39 374.05K $20.81M 0.46%
0.46%
New
40 312.92K $19.79M 0.44%
0.44%
Reduce
41 9.96M $19.21M 0.43%
0.43%
Hold
42 4.96M $19.00M 0.42%
0.42%
Add
43 742.54K $16.91M 0.38%
0.38%
New
44 80.34K $16.32M 0.36%
0.36%
Add
45 371.97K $13.27M 0.29%
0.29%
New
46 21.30K $10.51M 0.23%
0.23%
New
47 319.67K $10.39M 0.23%
0.23%
New
48 128.48K $10.01M 0.22%
0.22%
New
49 101.72K $9.66M 0.21%
0.21%
New
50 11.57K $8.50M 0.19%
0.19%
Reduce

FAQ

What did GLENVIEW CAPITAL MANAGEMENT, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC reported 54 equity positions worth $4.49B in aggregate; its largest disclosed positions were CVS ($617.96M), THC ($471.80M), GPN ($427.19M).

How large is GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio?

GLENVIEW CAPITAL MANAGEMENT, LLC reported $4.49B of long equity holdings across 54 positions as of 2025-Q3. Top-10 holdings account for 65.1% of reported value.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/glenview-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →